HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CIR To Consider Reopening Phthalates Safety Assessment

This article was originally published in The Rose Sheet

Executive Summary

With new studies suggesting an association between phthalate levels and diabetes, and a separate study proposing a link between phthalate levels and airway inflammation, the Cosmetic Ingredient Review Expert Panel will decide if the data merit reopening a safety review of phthalates.

Advertisement

Related Content

CIR: New Research On Controversial Ingredients Should Be Considered
CIR Moves To Reopen Retinol Assessment To Examine New Data
J&J To Remove Formaldehyde, Other Concerns From Personal-Care Items
FDA: No Asbestos Found In Talc Products Sampled, But Results Limited
CIR Panel Affirms Paraben Safety, Will Investigate Infant Skin Properties
CIR Requests Parabens Exposure Data, Reaffirms Phthalates Safety

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

RS018394

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel